EUVIMEDEUVIMED entdecken
Crossref

Immunogenicity of Chitosan-Based Non-invasive Vaccine Strategy Against Mycobacterium tuberculosis

Rasoul Hoseinpour, Alka Hasani, Behzad Baradaran, Jalal Abdolalizadeh, Roya Salehi, Akbar Hasani, Hossein Samadi Kafil, Edris Nabizadeh

ImmunoAnalysis · 2023

DOI: 10.34172/ia.2023.02 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoAnalysis, 2023. Verfasst von Rasoul Hoseinpour und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In spite of Bacillus Calmette-Guerin (BCG) vaccination, still tuberculosis caused by Mycobacterium tuberculosis remains a problematic impediment that requires perspective management. The aim of this study was to evaluate the immunogenicity of chitosan nanoparticles containing recombinant mycobacterial proteins and adjuvant in the Balb/C mice through a non-invasive nasal inhalation delivery route and measure the level of cytokines interferon gamma (IFN-γ), interleukin-4 (IL-4), and IL-17.

Methods

Thirty mice in five different groups were vaccinated through inhalation with compounds set in different combinations. Two weeks after the last nasal delivery, IFN-γ, IL-4, and IL-17 were measured in spleen cell culture supernatants.

Results

The IFN-γ and IL-17 concentrations were found to increase in the groups that received chitosan nanoparticles containing protein and adjuvant alone or as a BCG booster. Our study showed that the chitosan nanoparticle containing protein and adjuvant induced a Th1 response. However, the groups that first received BCG and then chitosan nanoparticles containing protein and adjuvant had the greatest Th1 response in terms of IFN-γ and IL-17 production in all the groups.

Conclusion

Our findings showed that the vaccine designed to be administered through the nasal mucosa well stimulates cellular immunity and enhances the BCG vaccine’s effectiveness.

Zitieren

APA

Hoseinpour, R., Hasani, A., Baradaran, B., Abdolalizadeh, J., Salehi, R., Hasani, A., Kafil, H. S., & Nabizadeh, E. (2023). Immunogenicity of Chitosan-Based Non-invasive Vaccine Strategy Against Mycobacterium tuberculosis. ImmunoAnalysis. https://doi.org/10.34172/ia.2023.02

Vancouver

Hoseinpour R, Hasani A, Baradaran B, Abdolalizadeh J, Salehi R, Hasani A, et al. Immunogenicity of Chitosan-Based Non-invasive Vaccine Strategy Against Mycobacterium tuberculosis. ImmunoAnalysis. 2023. doi:10.34172/ia.2023.02

BibTeX
@article{Hoseinpour2023,
  author = {Hoseinpour, Rasoul and Hasani, Alka and Baradaran, Behzad and Abdolalizadeh, Jalal and Salehi, Roya and Hasani, Akbar and Kafil, Hossein Samadi and Nabizadeh, Edris},
  title = {Immunogenicity of Chitosan-Based Non-invasive Vaccine Strategy Against Mycobacterium tuberculosis},
  journal = {ImmunoAnalysis},
  year = {2023},
  doi = {10.34172/ia.2023.02}
}
Kostenlos starten →